Índice

• • ·Editorial Board

    Página :CO2

    
• • ·Instructions to Authors

    Página :I

    

• Editorial

  • ·How Cool is Cryoablation?

    Página :425-426

    Stuart P. Thomas

    

• Original Articles

  • ·Treating Atrial Fibrillation: Pulmonary Vein Isolation with the Cryoballoon Technique

    Página :427-432

    Nick Jackson, Malcolm Barlow, James Leitch, John Attia

    Resumen Resumen Esquema Esquema  
  • ·Does Pregnancy Contribute to Systemic Right Ventricular Dysfunction in Adults with an Atrial Switch Operation?

    Página :433-438

    Dominica Zentner, Miriam Wheeler, Leeanne Grigg

    Resumen Resumen Esquema Esquema
  • ·A Comparison of Precipitants and Mortality When Acute Decompensated Heart Failure Occurs in the Community and Hospital Settings

    Página :439-443

    D.McD. Taylor, M. Ng Tang Fui, A.R. Chung, L. Gani, J.D. Zajac, L.M. Burrell

    Resumen Resumen Esquema Esquema
  • ·Single High Oral Dose Amiodarone for Cardioversion of Recent Onset Atrial Fibrillation

    Página :444-448

    Kugathasan Nadarasa, Michael J.A. Williams

    Resumen Resumen Esquema Esquema  

• Reviews

  • ·A Suggested Paradigm for Coronary Risk Screening in Asymptomatic Persons—Assessment of Total Coronary Atheromatous Burden

    Página :449-454

    Constantine N. Aroney

    Resumen Resumen Esquema Esquema  
  • ·Assessment of Platelet Function in Patients on Antiplatelet Therapy Undergoing Cardiac Surgery: A Review

    Página :455-462

    Ravi Patni, M. Asghar Nawaz, Antanas Macys, K.M. John Chan, P. Punjabi

    Resumen Resumen Esquema Esquema  
  • ·Novel Anticoagulants for Non-valvular Atrial Fibrillation

    Página :463-467

    Bo Xu, Robert Whitbourn

    Resumen Resumen Esquema Esquema  
  • ·Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation?

    Página :468-479

    Suchi Grover, Govin Srinivasan, Joseph B. Selvanayagam

    Resumen Resumen Esquema Esquema  

• Abstracts of The Cardiac Society of New Zealand, New Zealand Annual Scientific Meeting, 15-17 June 2012, Auckland, New Zealand

  • ·Medium-Term Follow up of Transcoronary Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

    Página :481

    P.D. Adamson, D. Smyth, J. Lainchbury

    
  • ·The Evaluation of Documentation in a Nurse and Medical Post Acute Coronary Syndrome Discharge Clinic

    Página :481

    C. Aldridge, A. Kerr, S. Oster, A. McLachlan

    
  • ·Ablation of Ventricular Tachycardia at Waikato Hospital

    Página :481-482

    R.F. Allen, S.C. Heald, D. Boddington, M.R. Webber, M.K. Stiles

    
  • ·Clinical Utilisation of Pro-BNP in the Exclusion of Congestive Heart Failure (CHF)

    Página :482

    C. Tromop van Dalen, A. Falloon, T. Boga

    
  • ·Urocortin-2 Increases Muscle Sympathetic Nerve Activity [MSNA] in Healthy Man

    Página :482

    W. Chan, D. Jardine, J. Butler, C. Charles, R. Troughton, M. Richards

    
  • ·Twenty-one Cases of Stress Cardiomyopathy Following the Christchurch, New Zealand 2011 Earthquake—Self Reported Health Outcome at 1 Year

    Página :482-483

    C. Chan, P. Bridgman, R. Troughton, J. Elliott

    
  • ·Integrated Effects of Urocortin-2 Infusion in Patients with Acute Decompensated Heart Failure: Findings from a Randomised Controlled Clinical Trial

    Página :483

    W. Chan, R. Troughton, C. Frampton, I. Crozier, M. Richards

    
  • ·Comparison of the Multiplate and VerifyNow Assays for Monitoring Residual Platelet Reactivity after Clopidogrel

    Página :483-484

    M. Chen-Xu, L. Johnston, A. Holley, A. Sasse, P.D. Larsen, S.A. Harding

     
  • ·Elevated Plasma Active Matrix Metalloproteinase 9 Level is Associated with Increased Diastolic Dysfunction Independent of Hypertension and Left Ventricular Hypertrophy in Patients with Coronary Artery

    Página :484

    J.W. Chu, G.T. Jones, G.P. Tarr, L.V. Phillips, G.T. Wilkins, A.M. van Rij, M.J.A. Williams

    
  • ·Valvular Heart Disease Mortality in New Zealand 1988 to 2007

    Página :484

    S. Coffey, B. Cox, M.J.A. Williams

    
  • ·Prognostic Value of Stress Perfusion Imaging with Cardiac MRI

    Página :484-485

    P. Ding, C. Edwards, A. To, J.P. Christiansen

     
  • ·One Year Outcomes after Treatment of Acute Myocardial Infarction (AMI) in 2010 are Improved Compared with Previous Years

    Página :485

    R. Lane, G. Campbell, C.M. Frampton, D.W. Smyth, J.M. Elliott

    
  • ·Is a “Small” Heart Attack a “Good” Heart Attack? One Year Outcomes after Acute Myocardial Infarction (AMI) in 2010 in Relation to Biomarker Elevations

    Página :485-486

    J.M. Elliott, R. Lane

    
  • ·Costly Time Delays for Weekend Acute Coronary Syndrome (ACS) Patient Admissions: Implications for Service Delivery

    Página :486

    C.J. Ellis, P. Horan, M. Gordon, G. Gamble

     
  • ·Factors Which Predict Individuals Whose Coronary Arteries are “Old Before Their Time”: The Value of Computed Tomographic (CT) Calcium Score Testing

    Página :486-487

    C.J. Ellis, M.E. Legget, C. Edwards, J.A. Ormiston, N. Van Pelt, R. Gabriel, B. Lowe, J. Christiansen, H. Winch, M. Osborne, G. Gamble

    
  • ·All Cause Mortality Following an Acute Coronary Syndrome (ACS) Admission: Six Year Follow-Up of the 2002 New Zealand (NZ) Acute Coronary Syndromes Audit

    Página :487-488

    C.J. Ellis, G.D. Gamble, G. Devlin, A. Hamer, J.M. Elliott, P. Matsis, M.J.A. Williams, S. Mann, J.K. French, A.M. Richards, H.D. White, For the Cardiac Society NZ ACS Audit Group

     
  • ·Is the Mortality Risk Following an Acute Coronary Syndrome (ACS) Admission to a Non-intervention Centre Related to Access to Cardiac Angiography? Eighteen Month Follow-up of the 2002/2007 New Zealand (NZ) ACS Audits

    Página :488

    CJ. Ellis, G.D. Gamble, A. Hamer, G. Devlin, J.M. Elliott, P. Matsis, M.J.A. Williams, S. Mann, J.K. French, A.M. Richards, H.D. White, For the Cardiac Society NZ ACS Audit Group

     
  • ·Acute Predict Cardiac Catheter Lab (CCL) One Year on—An Electronic Real-Time Audit, Quality Improvement Process in Middlemore Hospital CCL

    Página :489

    C. Flynn, J. White, S. Graham, A. McLachlan, D. Scott, P. Kay, A.J. Kerr

    
  • ·Reveal Loop Recorders—Should Follow Up Frequency be Driven by Patient Symptoms?

    Página :489

    M. Fowler, F. Riddell

    
  • ·Mortality, Morbidity and the Current Standard of Evidence-based Management Amongst Patients Living in Regional New Zealand with Severe Heart Failure (1997–2011): The Nelson Marlborough Heart Failure Study

    Página :489-490

    B.T. Grainger, S. White, S. Lake, R. Hipkiss, A. Hamer, N. Fisher, T. Pegg

    
  • ·Prognostic Utility of Cardiac Troponin in Patients with Possible Acute Coronary Syndromes Categorised by Degree of Coronary Artery Stenosis

    Página :490

    J.W. Hinton, A. McNally, S. Aldous

    
  • ·Plasma Antioxidant Enzyme Levels in Acute Coronary Syndrome

    Página :490

    A.S. Holley, L.R. Johnston, M. Chen-Xu, A. Sasse, P.D. Larsen, S.A. Harding

    
  • ·Subcutaneous ICDs and Shock Therapy: Lessons Learned

    Página :490-491

    M.A. Hood, F. Riddell, W.M. Smith

    
  • ·A Dedicated Cardiovascular Quality Assurance Programme in the Catheterisation Laboratory: A Novel Experience in New Zealand

    Página :491

    H.C. Humphreys, M. McAleer, S. El-Jack

    
  • ·High Residual Platelet Reactivity on Aspirin in a New Zealand ACS Population

    Página :491-492

    L.R. Johnston, A.S. Holley, M. Chen-Xu, A.C. La Flamme, D. Larsen, S.A. Harding

     
  • ·Variability in Platelet Reactivity and Biomarkers in Patients With Peripheral Vascular Disease

    Página :492

    L.R. Johnston, A.C. La Flamme, J.K. Wicks, D. Naik, P.D. Larsen, S.A. Harding

    
  • ·Eicosapentaenoic Acid Increases Plasma Adiponectin Concentration in Patients with Hyperlipidaema

    Página :492-493

    Y. Kajikawa, S. Takemoto, M. Ikeda

    
  • ·Role of CTCA in Acute Coronary Syndrome—Predicting Non-Significant Coronary Artery Disease

    Página :493

    S.H. Kueh, M. Lee, A.J. Kerr, N. van Pelt

    
  • ·Geographic, Ethnic and Socioeconomic Factors Influencing Access to Implantable-Cardioverter Defibrillators

    Página :493

    P.D. Larsen, D. Wilson, S.A. Harding, I. Melton, N.A. Lever, D. Boddington, S. Heald, M.K. Stiles

    
  • ·Estimating the Need for Implantable Cardioverter Defibrillators

    Página :494

    P.D. Larsen, L. Presant, S.A. Harding

    
  • ·ICD Therapy in Patients with Mustard and Senning Repair for D-Transposition of Great Arteries. The Greenlane/Auckland Hospital Experience

    Página :494

    M. Latif, B. Lowe

    
  • ·Cardiac Function in COPD Exacerbations

    Página :494-495

    M. Lee, A. Davies, C. Chang, M. Davis, R. Hancox

    
  • ·Percutaneous Lead Extraction: MDT Team Approach in Cardiac Catheter Labs

    Página :495

    N.A. Lever, J. Manson, R. Ullal, R. Cameron, S. Heald

    
  • ·Ambulatory Management of Congestive Heart Failure in the Rotorua and Taupo Communities

    Página :495

    S. Li, D. Aitken

    
  • ·Do Acute Coronary Syndrome Patients Categorised at High Risk by Grace Receive More Frequent and Earlier Coronary Angiography?

    Página :496

    A. Lin, A. Mustafa, G. Devlin, M. Lee, A. McLachlan, A.J. Kerr

    
  • ·How Well Does the Grace Score Perform in a New Zealand Acute Coronary Syndrome Cohort?

    Página :496

    A. Lin, A. Mustafa, M. Lee, G. Devlin, I. Ternouth, A. McLachlan, A.J. Kerr, on behalf of the all NZ ACS (ANZACS) QI group

    
  • ·Primary Percutaneous Coronary Intervention for Patients with St Elevation Myocardial Infarction—Past and Present at Auckland City Hospital

    Página :496-497

    A. Lin, J.L. Looi, K.L. Looi, K.L. Chow, F. Roberts, H.D. White, M. Webster, C.J. Ellis

     
  • ·Aortic–Mitral Annular Coupling in Mitral Valve Diseases: A Study with Real-Time 3-Dimensional Transoesophageal Echocardiography (RT3DE-TEE)

    Página :497-498

    J.L. Looi, Y.Y. Lam, C.M. Yu, P.W. Lee

     
  • ·Aortic–Mitral Annular Coupling Before and After Mitral Valve Repair: A Study with Real-Time Three-Dimensional Transoesophageal Echocardiography (RT3DE-TEE)

    Página :498

    J.L. Looi, Y.Y. Lam, C.M. Yu, P.W. Lee

     
  • ·Compulsory Collection of Key Performance Indicators at Point of Discharge Planning at Nelson Marlborough District Health Board: Do We Need It?

    Página :499

    K. Majeed, T. Pegg, N. Fisher, A. Hamer

    
  • ·Long-Term Effects of Cardiac Rehabilitation on Exercise Capacity and Cardiovascular Function in Coronary Artery Disease

    Página :499

    S. Mandic, M.J.A. Williams, E. Stevens, C. Brown, E.R. Nye, D. Body, L. Barclay, R. Walker

    
  • ·Effects of Community-Based Cardiac Rehabilitation on Physical Function and Body Composition in Coronary Artery Disease: 1.5-Year Follow-Up

    Página :499-500

    S. Mandic, C. Hodge, E. Stevens, H. Horwood, R. Walker, E.R. Nye, D. Body, M.J.A. Williams

    
  • ·A Decade of Cardiac Resynchronisation Therapy: The Green Lane and Auckland City Hospital Experience

    Página :500

    A. Martin, S. Sinclair, M. Hood, N. Lever, J. Stewart

    
  • ·Quality of Life Results after Insertion of Implantable Cardiac Defibrillators at Christchurch Hospital

    Página :500

    S. Matthewson, I. Crozier, J. Greenslade, K. Harvey, J. Inglis, I. Melton

    
  • ·Predictors of Mortality in the ICD Population

    Página :501

    R. McIntosh, P.-W. Lou, B. Shi, S.A. Harding, P.D. Larsen

     
  • ·Internet and Social Networking Use Amongst Patients Attending a South Auckland Cardiac Rehabilitation Program

    Página :501

    A. McLachlan, C. Aldridge, L. Ioelu, M. Morgan, K. McLean, L. Morley, J. Poole, A.J. Kerr

    
  • ·Will a High Dose Lipid Lowering Strategy be Tolerated by Both Patients and Clinicians; A Retrospective Audit

    Página :501-502

    A. Mclachlan, K. McLean, A.J. Kerr, A.P. Shanmuganathan

    
  • ·The Design and Implementation of a Pacific Cardiac Rehabilitation Program in South Auckland: The First Year

    Página :502

    K. McLean, L. Ioelu, L. Morley, A. McLachlan

    
  • ·Early Experience of Dabigatran Use in a Wellington Population

    Página :502

    J. Michel, D. Mundell, T. Boga, A. Sasse

    
  • ·New Zealand Cardiac Clinical Prioritisation System: Left Ventricular Impairment Predicts ICU Length of Stay after Coronary Artery Bypass Graft Surgery

    Página :503

    J.M. Michel, N.M. Shah, G. Ashton, A. Psirides, B.D. Mahon, P.D. Larsen, A.S. Sasse

     
  • ·Does EuroSCORE Predict Preoperative Complications in Patients Awaiting Coronary Artery Bypass Surgery: Lessons from the Clinical Cardiac Prioritisation System Database

    Página :503-504

    J.M. Michel, N.M. Shah, G. Ashton, A. Psirides, B.D. Mahon, A.S. Sasse

     
  • ·Evaluation of the Middlemore Hospital Cardiac Rehabilitation (CR) Exercise Program

    Página :504

    M. Morgan, I. Zeng, A. McLachlan

    
  • ·Strain and Pacing Study; Role of Pacing Lead Placement in LV Contraction

    Página :504-505

    A.M. Morgan, M. Webber, S. Harding, A. Scully, J. Sexton, L. Johnson, P. Larsen, A. Sasse

    
  • ·A Quality Improvement Process: Pacific Community Focused Cardiac Rehabilitation

    Página :505

    L. Morley, K. McLean, A. McLachlan

    
  • ·Role of Cardiac MRI in Patients Presenting with Acute Coronary Syndrome with Normal or Minor Coronary Artery Disease

    Página :505

    D. Mundell, T. Boga, K. Ferrier

    
  • ·Thrombolysis in STEMI: A Two-Year Clinical Experience in Tauranga Hospital

    Página :505-506

    A.H.S. Mustafa, N. Wijesuriya, G.F. Porter, J. Tisch, C. Young, D. Boddington, S. Tie

    
  • ·Ethnicity and Revascularisation Following Acute Coronary Syndromes: A Four-Year Cohort Study

    Página :506

    A.H.S. Mustafa, A. Lin, M. Lee, A. McLachlan, A.J. Kerr

    
  • ·The Impact of Direct ECG Transmission from Ambulance to Cardiologist on PAMI Treatment Delays

    Página :506

    C.M. Nunn, G.P. Devlin

     
  • ·Surgical Repair of Adult Coarctation in Auckland

    Página :506-507

    T. Oh, K. Finucane

    
  • ·“Between a Rock and a Hard Place”: Post ICD Shock Stress Reactions

    Página :507

    M.L. Garland, L. Painter, M. Johnson, N. Lever

    
  • ·The Shocking Truth: Psychological Impact of Shocks and Storms for Implantable Cardioverter Defibrillator (ICD) Patients

    Página :507

    M.L. Garland, L. Painter, M. Johnson, N. Lever

    
  • ·Medtronic Carelink Remote Monitoring the Auckland City Hospital (ACH) Setup Experience

    Página :508

    C. Pearson, S. Sinclair, F. Riddell

     
  • ·Ability of General Physician to Correctly Interpret Pacing Indications

    Página :508-509

    J. Pemberton

    
  • ·Prognostic Significance of Atrial Fibrillation in Acute Heart Failure Admissions: The New Zealand Heart Failure Registry

    Página :509

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Prevalence of Hyponatraemia in Acute Heart Failure Admissions and Short Term Outcomes: The New Zealand Heart Failure Registry

    Página :509

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Gender Differences in Acute Heart Failure Admissions and Short Term Outcomes: The New Zealand Heart Failure Registry

    Página :510

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Reviewing the Use of Pre-Hospital ECG in Management of Patients with Suspected ST Elevation Myocardial Infarction (STEMI)

    Página :510

    S. Plunkett, T. O’Meeghan, T. Boga

    
  • ·Apical Ballooning Syndrome and Stress

    Página :510-511

    J. Poole, J. Main, C. Roberts, L. Morley, I. Zeng, K. McLean, C. Aldridge, A. Kerr, A. McLachlan

    
  • ·The Prediction of Fat Free Mass for Indexation of Echo Measurements

    Página :511

    K.K. Poppe, R.N. Doughty, G.A. Whalley, C.M. Triggs

     
  • ·Improved Cardiovascular Risk Estimation in People with Type 2 Diabetes Mellitus: Potential Role of Specialised Risk Equations and CT Coronary Calcium Score

    Página :511-512

    K.K. Poppe, N. van Pelt, S. Bhattacharyya, G.A. Whalley, R.N. Doughty

     
  • ·Aortic and Left Ventricular Function During Rest and Exercise Using Magnetic Resonance Imaging

    Página :512

    P.A. Roberts, M. Peters, A. Okamura, Y. Liu, B. Cowan, A. Young

    Esquema Esquema
  • ·Similar Long-Term Outcomes After ST Elevation Myocardial Infarction Treated with Everolimus Eluting Stents or Bare Metal Stents

    Página :512-513

    R.R. Saireddy, J. Elliott, D. Smyth, D. McClean, J. Blake

    
  • ·Validation Study of Cardiac Clinical Prioritisation Score (CPS) for Coronary Artery Bypass Grafting

    Página :513

    A.S. Sasse, J.M. Michel, N.M. Shah, G. Ashton, S.A. Harding, B.D. Mahon, P.D. Larsen

    
  • ·Do Cardiovascular Risk Factors Predict Complications in Patients Awaiting Coronary Artery Bypass Grafting

    Página :513-514

    N.M. Shah, J.M. Michel, G. Ashton, A. Psirides, B.D. Mahon, P.D. Larsen, A.S. Sasse

     
  • ·Complex Transradial Percutaneous Coronary Intervention Using a Sheathless Guide Catheter

    Página :514

    N.M. Shah, A.S. Sasse, P.P. Matsis, P.D. Larsen, S.A. Harding

    
  • ·ECG Markers of Arrhythmogeneic Substrate and Structural Heart Disease

    Página :514

    B. Shi, K. Ferrier, A. Sasse, S.A. Harding, P.D. Larsen

    
  • ·Predictors of Intervention in Acute Coronary Syndrome Patients with pre-Existing Bypass Grafts

    Página :515

    T.A.C. Snow, T. Watson, P.N. Ruygrok, M.W. Webster, J.T. Stewart

    
  • ·The Predictive Value of Microvolt T Wave Alternans in Patients with Implanted Defibrillators

    Página :515

    J.A. Sutherand, I.C. Melton, H.J. Earl, K.P. Dredge, S.J. Aldous, S. Matthewson, I.G. Crozier

    
  • ·Medium Term Success Rates of Pulmonary Vein Isolation for Atrial Fibrillation

    Página :515-516

    J. Swampillai, I. Gray, M.R. Webber, D. Boddington, S.C. Heald, M.K. Stiles

    
  • ·Diagnostic Yield of Implantable Loop Recorders in Patients with Unexplained Syncope

    Página :516

    J. Swampillai, R.F. Allen, S. Levings, M.R. Webber, C.M. Wade, M.K. Stiles, S.C. Heald

    
  • ·Use of Exercise Tolerance Test in Intermediate Risk non-ST Elevation Acute Coronary Syndrome

    Página :516

    P. Tamuno, J. Mazhar, J. Swampillai, V. Pera, A. Kerr, G. Devlin

    
  • ·Single Versus Multi-Vessel PCI in STEMI Patients with Multivessel Coronary Artery Disease in Dunedin Public Hospital

    Página :517

    C.L.H. Tie, V.H.T. Chen, G.T. Wilkins, M.J.A. Williams, C.K. Wong, P. Herbison, E.C. McKay, L. Vardi, A. Middleton

    
  • ·The Essential Roles of Nurse Specialist in Delivering CT Coronary Angiography Service in the Acute Chest Pain Setting

    Página :517

    J. Wickham, H. Brannigan, J. Carr, J.P. Christiansen, C. Edwards, D. Cranefield, H.H. Hart, A.C.Y. To

    
  • ·Incorporating CT Coronary Angiography in the Acute Chest Pain Pathway—An Efficient Model of Resource Utilisation

    Página :517-518

    A.C.Y. To, J.P. Christiansen, C. Edwards, D. Cranefield, H.H. Hart, J. Wickham

    
  • ·Delay to Surgical Revascularisation Post Acute Coronary Syndromes—Middlemore Hospital

    Página :518

    J. Voss, I. Caldwell, A. Kerr

    
  • ·Early Prevent Pilot: Towards the Systemic Use of Dispensing Records to Prevent Treatment Gaps Early After Acute Coronary Syndromes-Proof of Concept

    Página :518

    J. Voss, A. McLachlan, T. Riddell, S. Bhattacharya, J. Warren, A.J. Kerr

    
  • ·Mitral Valve Endocarditis Audit—Auckland City Hospital

    Página :518-519

    J. Voss, S. Chung, C. Kasargod, J. Pemberton

    
  • ·Bone Density Before and After Heart or Lung Transplantation—A Longitudinal Study

    Página :519

    T.K.M. Wang, S. O’Sullivan, G.D. Gamble, P.N. Ruygrok

    
  • ·New Parenthood After Heart Transplantation

    Página :519

    A. Ruygrok, H. Gibbs, E. Painter, A. Coverdale, P. Ruygrok, C. Wasywich

    
  • ·Same-Day Discharge is Safe in Patients with Low-Level Troponin Elevation post-PCI

    Página :520

    I.G. Webb, M.B. Simmonds, P.D. Larsen, S.A. Harding

    
  • ·Elevated Baseline Cardiac Troponin Levels in the Elderly—Another Variable to Consider?

    Página :520-521

    I.G. Webb, S.T. Yam, R. Cooke, A. Aitken, P.D. Larsen, S.A. Harding

     
  • ·Implantable Cardioverter Defibrillator Registry in New Zealand—Initial Experience

    Página :521

    H.S. Millow, M.R. Webber, P.D. Larsen, S.A. Harding, S.C. Heald, M.K. Stiles

    
  • ·Prevalence of Atrial Fibrillation in Maori and non-Maori Inpatients in the Waikato Region

    Página :521-522

    M.R. Webber, M. Mannakarra, J. Swampillai, I. Gray, M.K. Stiles

    
  • ·Periprocedural Dabigatran in Patients Undergoing Electrophysiology Procedures

    Página :522

    M.R. Webber, I. Gray, M.K. Stiles

    
  • ·Significant Bias Associated with Left Ventricular Volume Measurements by MRI Compared to Echo (2D, 2D-Contrast and 3D)—A Systematic Review

    Página :522-523

    S. Anandabaskaran, J. Christiansen, R. Doughty, R. Gabriel, G. Whalley

    
  • ·Implantable Cardioverter Defibrillator (ICE) Use in Hypertrophic Cardiomyopathy—Ten-Year Auckland Experience

    Página :523

    J. White, S. Sinclair, F. Riddell, M. Hood, N. Lever, W. Smith

    
  • ·Safety of Conscious Sedation for Cardiology Procedures at Auckland Hospital

    Página :523

    J. White, A. Martin, N. Lever

    
  • ·Excessive Cardiovascular Risk and Cardiac Investigations in Asymptomatic Population: A Study in Airline Pilots

    Página :524

    I.M.A. Wirawan, S. Aldington, R.F. Griffiths, C.J. Ellis, P.D. Larsen

    
  • ·Vitamins B₁₂ and C Supplementation Improves Arterial Reactivity and Structure in Passive Smokers

    Página :524

    K.S. Woo, P. Chook, M.L. Chiu, X.H. Feng, M.L. Evora, K.V. Koon, X.M. Zhang, C.L. Chu, H.C. Leong, T.W.C. Yip, T.Y.K. Chan

    
  • ·VF Waveform Complexity at ICD Implant is Predictive of Future ICD Therapy

    Página :525

    E.L. Woodcock, N.A. Lever, P.D. Larsen

     
  • ·Ventricular Fibrillation Characteristics: What Measurements are Best?

    Página :525

    E.L. Woodcock, N.A. Lever, P.D. Larsen

    
  • ·Must Low Risk Radial Access Coronary Angiography Outweigh Potentially High Risk Femoral Access as an Approach of Choice? Experiences from Four Years of Angiography and Intervention at North Shore Hospital

    Página :525-526

    M.B. McAleer, S. El-Jack, B. O’Shaughnessy

    

• Societies

  • ·Heart Foundation

    Página :527

    
  • ·The Cardiac Society of Australia and New Zealand

    Página :528-529